Production (Stage)
Quoin Pharmaceuticals, Ltd.
QNRX
$8.74
$0.212.46%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.55M | 14.06M | 10.31M | 12.57M | 14.69M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 384.20K | 869.10K | 190.50K | 650.70K | 574.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 559.90K | -- | -- | -- | -- |
| Total Current Assets | 12.50M | 14.93M | 10.50M | 13.22M | 15.26M |
|
|
|||||
| Total Current Assets | 12.50M | 14.93M | 10.50M | 13.22M | 15.26M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 458.30K | 483.30K | 508.30K | 533.30K | 558.30K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 300.00K | 383.40K | 300.00K | 300.00K |
| Total Assets | 12.96M | 15.71M | 11.39M | 14.05M | 16.12M |
|
|
|||||
| Total Accounts Payable | 644.10K | 905.70K | 222.60K | 819.70K | 358.50K |
| Total Accrued Expenses | 3.61M | 2.68M | 2.65M | 2.53M | 3.27M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 600.00K | 600.00K | 600.00K | 600.00K | 600.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 4.86M | 4.18M | 3.47M | 3.95M | 4.22M |
|
|
|||||
| Total Current Liabilities | 4.86M | 4.18M | 3.47M | 3.95M | 4.22M |
| Long-Term Debt | 2.17M | 2.32M | 2.47M | 2.62M | 2.77M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.03M | 6.50M | 5.95M | 6.58M | 7.00M |
|
|
|||||
| Common Stock & APIC | 64.90M | 64.37M | 58.30M | 57.98M | 57.66M |
| Retained Earnings | -58.98M | -55.17M | -52.85M | -50.50M | -48.53M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 5.93M | 9.20M | 5.44M | 7.48M | 9.13M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.93M | 9.20M | 5.44M | 7.48M | 9.13M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.93M | 9.20M | 5.44M | 7.48M | 9.13M |
|
|
|||||